ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0100967765290133 0.012735763
NSC 100880 Camptothecin 0.0135588245836371 0.67145827
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0135588245836371 0.039287954
NSC 154948 M-AMSA 0.0135588245836371 0.54803038
NSC 244404 Null 0.0135588245836371 0.19023438
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0135588245836371 0.54107967
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0135588245836371 0.24357909
NSC 300289 Pinafide 0.0135588245836371 0.57570451
NSC 33570 Null 0.0135588245836371 0.13300533
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0135588245836371 0.1236203
Total:119  Current:31    [First] [Prev] [Next] [Last]